Antibody neutralizes SARS and COVID-19 coronaviruses
The neutralizing antibody, called S309, is on an accelerated path toward clinical trials, UW Medicine Newsroom

An antibody first identified in a blood sample from a patient who recovered from Severe Acute Respiratory Syndrome in 2003 inhibits related coronaviruses, including the cause of COVID-19. The antibody, called S309, is now on a fast-track development and testing path at Vir Biotechnology in the next step toward possible clinical trials.